The Carlyle Group Inc. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-21 4:31 pm Sale | 2024-10-17 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,003,101 4.990% | -464,998 (-18.84%) | Filing |
| 2024-10-15 4:31 pm Sale | 2024-10-10 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,468,099 6.200% | -782,979 (-24.08%) | Filing |
| 2024-10-10 4:30 pm Sale | 2024-10-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 3,251,078 8.100% | -745,287 (-18.65%) | Filing |
| 2024-09-10 6:30 pm Purchase | 2024-09-06 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 3,996,365 9.990% | 1,102,750 (+38.11%) | Filing |
| 2023-10-16 4:30 pm Purchase | 2023-10-12 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,893,615 9.990% | 1,326,368 (+84.63%) | Filing |
| 2023-10-03 4:05 pm Purchase | 2023-09-28 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,567,247 9.990% | 339,930 (+27.70%) | Filing |
| 2023-08-18 4:15 pm Purchase | 2023-08-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,227,317 12.300% | 1,227,317 (New Position) | Filing |
| 2023-05-10 4:32 pm Unchanged | 2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-12-20 4:30 pm Sale | 2022-12-16 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | -1,224,571 (Position Closed) | Filing |
| 2022-08-11 4:56 pm Purchase | 2022-08-01 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,224,571 15.300% | 1,224,571 (New Position) | Filing |